New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva ...

That equation led Vyvgart, argenx’s treatment for generalized myasthenia gravis (gMG), to take the top spot, with an overall score of 3.9. Cabenuva, GSK’s long-acting HIV treatment ...